UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000020585
Receipt No. R000023766
Scientific Title Investigator initiated Phase II Study of Gedatolisib in Advanced Recurrent Small-Cell Lung Cancer Patients harboring Molecular Alterations in PI3K/AKT/mTOR Pathway
Date of disclosure of the study information 2016/02/01
Last modified on 2020/08/12 08:36:51

No. Disposal Last modified on Item of update
1 Insert 2016/01/15 18:51:44
2 Update 2016/02/12 09:35:07 Primary outcomes
Primary outcomes
3 Update 2016/02/12 09:36:36 Acronym
Acronym
4 Update 2016/03/01 12:22:05 Recruitment status
Anticipated trial start date
5 Update 2016/12/14 09:32:39 Recruitment status
6 Update 2017/01/16 08:51:26 Narrative objectives1
7 Update 2017/01/16 08:55:20 Division name
Name of primary sponsor
Organization
Category of Funding Organization
8 Update 2017/01/16 09:05:17 Institutions
9 Update 2017/06/16 09:25:43 Key exclusion criteria
10 Update 2020/01/17 09:56:44 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address

Last name of contact person

Last name of contact person
Zip code
Address
Organization
Organization
Address
Address
Tel
Email
11 Update 2020/01/17 10:03:28 Date of IRB
Last follow-up date
12 Update 2020/07/20 08:38:19 Recruitment status
13 Update 2020/08/12 08:36:51 Recruitment status


Contact us.